These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Cardiovascular risk of haloperidol vs. atypical anti-psychotic drugs in schizophrenia treatment].
    Author: Dobrin I, Dobrin RP, Chele G, Stefănescu C, Knieling A, Chiriţă R.
    Journal: Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):658-61. PubMed ID: 21243790.
    Abstract:
    The present study examined the safety of the atypical antipsychotic drugs sertindol, olanzapine and quetiapine used in the treatment of schizophrenia. Haloperidol, a typical antipsychotic drug, was used for comparison. These data may account for the different therapeutic effects and side-effect profiles (cardiovascular risk) of typical and atypical antipsychotic drugs in schizophrenia.
    [Abstract] [Full Text] [Related] [New Search]